Free Trial

Rentokil Initial plc (NYSE:RTO) Shares Acquired by Balyasny Asset Management L.P.

Rentokil Initial logo with Business Services background

Balyasny Asset Management L.P. lifted its holdings in Rentokil Initial plc (NYSE:RTO - Free Report) by 72.9% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 28,577 shares of the company's stock after purchasing an additional 12,049 shares during the period. Balyasny Asset Management L.P.'s holdings in Rentokil Initial were worth $724,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Cape Investment Advisory Inc. lifted its position in shares of Rentokil Initial by 65.2% in the 4th quarter. Cape Investment Advisory Inc. now owns 1,505 shares of the company's stock worth $38,000 after purchasing an additional 594 shares during the period. CENTRAL TRUST Co lifted its position in shares of Rentokil Initial by 15,208.3% in the 4th quarter. CENTRAL TRUST Co now owns 1,837 shares of the company's stock worth $47,000 after purchasing an additional 1,825 shares during the period. Smartleaf Asset Management LLC lifted its position in shares of Rentokil Initial by 486.7% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,942 shares of the company's stock worth $49,000 after purchasing an additional 1,611 shares during the period. Cromwell Holdings LLC purchased a new stake in shares of Rentokil Initial in the 4th quarter worth approximately $59,000. Finally, Blue Trust Inc. lifted its position in shares of Rentokil Initial by 140.4% in the 4th quarter. Blue Trust Inc. now owns 2,402 shares of the company's stock worth $60,000 after purchasing an additional 1,403 shares during the period. Hedge funds and other institutional investors own 9.91% of the company's stock.

Rentokil Initial Stock Down 0.1%

NYSE:RTO traded down $0.02 during midday trading on Tuesday, reaching $23.54. 47,594 shares of the stock traded hands, compared to its average volume of 778,456. Rentokil Initial plc has a 12-month low of $19.60 and a 12-month high of $34.07. The business has a 50-day moving average of $22.58 and a two-hundred day moving average of $24.29. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.96 and a current ratio of 1.04. The stock has a market capitalization of $11.88 billion, a PE ratio of 15.60, a price-to-earnings-growth ratio of 7.95 and a beta of 0.96.

Rentokil Initial Announces Dividend

The company also recently announced a semi-annual dividend, which was paid on Thursday, May 15th. Investors of record on Friday, April 4th were given a dividend of $0.3825 per share. The ex-dividend date of this dividend was Friday, April 4th. This represents a yield of 2.4%. Rentokil Initial's payout ratio is 45.03%.

Analyst Upgrades and Downgrades

RTO has been the subject of several research reports. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating on shares of Rentokil Initial in a research report on Friday, March 7th. Sanford C. Bernstein cut shares of Rentokil Initial from a "market perform" rating to an "underperform" rating in a research report on Thursday, May 15th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, one has assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy".

View Our Latest Research Report on Rentokil Initial

Rentokil Initial Profile

(Free Report)

Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.

Read More

Institutional Ownership by Quarter for Rentokil Initial (NYSE:RTO)

Should You Invest $1,000 in Rentokil Initial Right Now?

Before you consider Rentokil Initial, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rentokil Initial wasn't on the list.

While Rentokil Initial currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Defense Stocks Set to Crush the S&P This Summer
Analysts Are Watching These 4 Penny Stocks—You Should Too
Congress Is Pouring Millions Into These 6 Surprising Stocks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines